Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces the previous Revision: v3.4.1 on the page. This update appears to be a site version change with no evident impact on the study details or user actions.
    Difference
    0.0%
    Check dated 2026-02-17T03:23:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 to the page header. Removed the lapse-in-funding notice and the previous Revision: v3.4.0 reference.
    Difference
    0.3%
    Check dated 2026-02-09T22:32:47.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    New notice banner informs users of a lapse in government funding and potential downtime. It states that the NIH Clinical Center is open and provides links to cc.nih.gov and opm.gov for current operating status.
    Difference
    0.2%
    Check dated 2026-02-02T18:36:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a glossary display, updated the QC label to 'Last Update Submitted that Met QC Criteria', standardized capitalization for 'No FEAR Act Data', and bumped the site revision to v3.4.0 (from v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-26T19:30:28.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this is a minor version change with no alterations to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T13:46:00.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added new study locations (California and several states) and updated to revision v3.3.3, replacing the previous location groupings.
    Difference
    0.7%
    Check dated 2025-12-22T01:50:01.000Z thumbnail image

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.